Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like EtherCAT Technology Group announces vendor-independent diagnosis interface December 6, 2018 OPC Foundation announces standardization and harmonization initiative for OPC UA including TSN enabled Ethernet networks November 5, 2018 Financial investors joining hands with utilities to acquire power projects March 19, 2017
OPC Foundation announces standardization and harmonization initiative for OPC UA including TSN enabled Ethernet networks November 5, 2018